David Mullarkey
Directeur Général chez ClearNote Health, Inc.
Profil
David Mullarkey is currently the Chief Executive Officer & Director at ClearNote Health, Inc. He was previously the President, Chief Executive Officer & Director at Omniome, Inc. and the Director-Strategic Marketing at Johnson & Johnson.
He also held positions as Principal at Eli Lilly & Co., Coopers & Lybrand LLP, and SCIREX Corp.
He was the Vice President-Marketing at Dow Pharmaceutical Sciences, Inc. and the Senior VP & General Manager-Dermatology at Bausch Health Cos., Inc. Additionally, he served as the Chief Operating Officer at Ariosa Diagnostics, Inc. Mr. Mullarkey received his undergraduate degree from Cornell University and his MBA from Kellogg School of Management.
Postes actifs de David Mullarkey
| Sociétés | Poste | Début |
|---|---|---|
ClearNote Health, Inc.
 ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology ClearNote Health, Inc. is a company that develops liquid biopsy tests to detect cancers with high mortality rates early when they respond best to treatment. ClearNote Health is based in San Mateo, CA. The company uses its proprietary epigenomics platform to analyze individuals' changing biology that is yet to produce symptoms. The company was founded by Stephen D. Quake, and David Mullarkey has been the CEO of the company since 2022. | Directeur Général | 10/01/2022 |
Anciens postes connus de David Mullarkey
| Sociétés | Poste | Fin |
|---|---|---|
Omniome LLC
 Omniome LLC Miscellaneous Commercial ServicesCommercial Services Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA. | Directeur Général | 20/11/2020 |
| JOHNSON & JOHNSON | Sales & Marketing | 01/01/2006 |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Directeur des opérations | - |
| BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de David Mullarkey
| Cornell University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| BAUSCH HEALTH COMPANIES INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Omniome LLC
Omniome LLC Miscellaneous Commercial ServicesCommercial Services Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA. | Commercial Services |
| Coopers & Lybrand LLP | Commercial Services |
Dow Pharmaceutical Sciences, Inc.
 Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Distribution Services |
| SCIREX Corp. | Commercial Services |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Health Services |
ClearNote Health, Inc.
ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology ClearNote Health, Inc. is a company that develops liquid biopsy tests to detect cancers with high mortality rates early when they respond best to treatment. ClearNote Health is based in San Mateo, CA. The company uses its proprietary epigenomics platform to analyze individuals' changing biology that is yet to produce symptoms. The company was founded by Stephen D. Quake, and David Mullarkey has been the CEO of the company since 2022. | Health Technology |